BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8033810)

  • 1. Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus.
    Gadot M; Leibowitz G; Shafrir E; Cerasi E; Gross DJ; Kaiser N
    Endocrinology; 1994 Aug; 135(2):610-6. PubMed ID: 8033810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased susceptibility of islets from diabetes-prone Psammomys obesus to the deleterious effects of chronic glucose exposure.
    Gross DJ; Leibowitz G; Cerasi E; Kaiser N
    Endocrinology; 1996 Dec; 137(12):5610-5. PubMed ID: 8940391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin secretion in obese and non-obese NIDDM.
    Cerasi E; Nesher R; Gadot M; Gross D; Kaiser N
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S27-37. PubMed ID: 8529516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the beta-cell.
    Gadot M; Ariav Y; Cerasi E; Kaiser N; Gross DJ
    Endocrinology; 1995 Oct; 136(10):4218-23. PubMed ID: 7664638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical investigation of insulin secretion by pancreatic beta-cells in control and diabetic Psammomys obesus.
    Bendayan M; Malide D; Ziv E; Levy E; Ben-Sasson R; Kalman R; Bar-On H; Chrétien M; Seidah N
    J Histochem Cytochem; 1995 Aug; 43(8):771-84. PubMed ID: 7622840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-regulated proinsulin gene expression is required for adequate insulin production during chronic glucose exposure.
    Leibowitz G; Uçkaya G; Oprescu AI; Cerasi E; Gross DJ; Kaiser N
    Endocrinology; 2002 Sep; 143(9):3214-20. PubMed ID: 12193532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.
    Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N
    Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome.
    Kaiser N; Bailyes EM; Schneider BS; Cerasi E; Steiner DF; Hutton JC; Gross DJ
    Diabetes; 1997 Jun; 46(6):953-7. PubMed ID: 9166665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet-induced diabetes in the sand rat (Psammomys obesus).
    Kaiser N; Cerasi E; Leibowitz G
    Methods Mol Biol; 2012; 933():89-102. PubMed ID: 22893403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From sand rats to diabetic patients: is non-insulin-dependent diabetes mellitus a disease of the beta cell?
    Cerasi E; Kaiser N; Gross DJ
    Diabetes Metab; 1997 Mar; 23 Suppl 2():47-51. PubMed ID: 9105783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on insulin production sorting and secretion by major histocompatibility complex class II gene expression in the pancreatic beta-cell of transgenic mice.
    Grodsky GM; Ma YH; Cullen B; Sarvetnick N
    Endocrinology; 1992 Aug; 131(2):933-8. PubMed ID: 1639031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperproinsulinaemia and islet dysfunction in the NIDDM-like syndrome of Psammomys obesus.
    Kaiser N; Gadot M; Leibowitz G; Cerasi E; Gross DJ
    Adv Exp Med Biol; 1997; 426():371-8. PubMed ID: 9544296
    [No Abstract]   [Full Text] [Related]  

  • 13. An in vivo analysis of pancreatic protein and insulin biosynthesis in a rat model for non-insulin-dependent diabetes.
    Permutt MA; Kakita K; Malinas P; Karl I; Bonner-Weir S; Weir G; Giddings SJ
    J Clin Invest; 1984 May; 73(5):1344-50. PubMed ID: 6232285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid polypeptide in Psammomys obesus: lack of correlation between insulin resistance and plasma IAPP levels.
    Duhault J; Boulanger M; Espinal J; Marquié G; Petkov P; Donev S; Jablenska R; Popov A
    Cell Mol Biol (Noisy-le-grand); 1994 Jun; 40(4):535-40. PubMed ID: 8061570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus.
    Vedtofte L; Bodvarsdottir TB; Gotfredsen CF; Karlsen AE; Knudsen LB; Heller RS
    Regul Pept; 2010 Feb; 160(1-3):106-14. PubMed ID: 20005262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment.
    Leckström A; Ziv E; Shafrir E; Westermark P
    Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats.
    Leahy JL
    Diabetes; 1993 Jan; 42(1):22-7. PubMed ID: 8420818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinsulin and C-peptide: a review.
    Kitabchi AE
    Metabolism; 1977 May; 26(5):547-87. PubMed ID: 403392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.